semaglutide medication class GLP-1 Medications for Weight Loss: vs Tirzepatide vs Retat – Revolution Health & Wellness Rybelsus (semaglutide): Uses, Side Effects,

The agreement includes provisions requiring certain TransCon technology-based products to be identified and advanced in metabolic diseases to maintain exclusivity in the field and additional provisions for cardiovascular diseases

Theres going to likely be additional possible complications added to the label, especially because these drugs are so widely used these days

Novo Nordisk's data exclusivity for semaglutide expired in Canada on January 4, 2026 [Source: glp1prices.ca/glp1-news/health-canada-reviewing-eight-more-generic-semaglutide-submissions-may-2026]

Semaglutide, a GLP-1 receptor agonist, and Tirzepatide, a dual GIP and GLP-1 receptor agonist, are medications that mimic the action of incretin hormones, which play a crucial role in regulating blood sugar and appetite

body composition also plays a role